coomassie brilliant blue has been researched along with Spinal Cord Injuries in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, C; Li, C; Wang, Y; Wang, Z; Wu, L; Yang, Y; Zhou, X | 1 |
| Bekar, L; Blum, L; Cotrina, ML; Goldman, SA; Han, X; Nedergaard, M; Peng, W; Takano, T; Tian, GF; Yu, H | 1 |
| Bramlett, HM; Dietrich, WD; Frydel, B; Marcillo, A | 1 |
3 other study(ies) available for coomassie brilliant blue and Spinal Cord Injuries
| Article | Year |
|---|---|
Brilliant Blue G Inhibits Inflammasome Activation and Reduces Disruption of Blood-Spinal Cord Barrier Induced by Spinal Cord Injury in Rats.
Topics: Animals; Inflammasomes; Male; Neuroprotective Agents; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Spinal Cord; Spinal Cord Injuries; Spine | 2019 |
Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Humans; Indicators and Reagents; Neuroprotective Agents; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Recovery of Function; Rosaniline Dyes; Spinal Cord; Spinal Cord Injuries; Time Factors | 2009 |
A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.
Topics: Animals; Contusions; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Neuroprotective Agents; Purinergic P2X Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Spinal Cord Injuries | 2012 |